Non-interventional Prospective Observational Study to Describe EGB 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders. (TAYPES)

NCT02321475 COMPLETED

The purpose of this study is to determine the effectiveness of EGb 761® (Tanakan®) in Russian patients of middle age and younger, suffering from psycho-emotional symptoms added to cognitive disorders based on the improvement of FAM test (feeling-healthy, activity, mood test) score.

Details

Lead sponsor	Ipsen
Status	COMPLETED
Enrolment	54
Start date	2014-06
Completion	2015-04

Conditions

• Cognitive Disorders

Interventions

• EGb761®

Primary outcomes

• Percentage of patients with increase of total medium FAM test score ≥1 after 3 months treatment — 3 months
  The FAM test is a questionnaire using three subscales (i.e. General health, Activity, and Mood). Scores for each subscale range from 3 to -3 (where -3 is bad and 3 is good). The total for each subscale and arithmetical mean is calculated.

Countries

Russia